Rubius Therapeutics, Inc. (RUBY)

Exchange NASDAQ
0.97


Currency in USD (Disclaimer)
Volume:
Day's Range:

RUBY Insider Trading

Transaction Date Reporting Name Relationship Shrs. Owned Type Acq./Disp. Shrs. Transacted Price(USD) Amount(USD) SEC Filing
2022-05-12 Holles Natalie C. director 25,000.0 A-Award A 25,000.0 1.24 31,000.00
2022-05-12 Prener Anne director 25,000.0 A-Award A 25,000.0 1.24 31,000.00
2022-05-12 Symonds Jonathan director 25,000.0 A-Award A 25,000.0 1.24 31,000.00
2022-05-12 AFEYAN NOUBAR director, 10 percent owner 25,000.0 A-Award A 25,000.0 1.24 31,000.00
2022-05-12 Sohn Catherine A. director 25,000.0 A-Award A 25,000.0 1.24 31,000.00
2022-05-12 Rosenblatt Michael director 25,000.0 A-Award A 25,000.0 1.24 31,000.00
2022-05-12 Cuss Francis M director 25,000.0 A-Award A 25,000.0 1.24 31,000.00
2022-05-12 Epstein David R director 499,762.0 A-Award A 499,762.0 1.24 619,704.88
2022-04-21 Epstein David R director 4,720,012.0 P-Purchase A 30,000.0 1.44 43,329.00
2022-02-01 CAGNONI PABLO J director, officer: CEO and President 100,000.0 A-Award D 100,000.0 0.00 0.00
2022-02-01 CAGNONI PABLO J director, officer: CEO and President 365,000.0 A-Award D 365,000.0 6.75 2,463,750.00
2022-02-01 CAGNONI PABLO J director, officer: CEO and President 63,750.0 M-Exempt D 21,250.0 0.00 0.00
2022-02-01 CAGNONI PABLO J director, officer: CEO and President 35,520.0 S-Sale D 6,730.0 6.57 44,236.29
2022-02-01 Turka Laurence A. officer: Chief Scientific Officer 34,500.0 A-Award D 34,500.0 0.00 0.00
2022-02-01 Turka Laurence A. officer: Chief Scientific Officer 143,750.0 A-Award D 143,750.0 6.75 970,312.50
2022-02-01 Turka Laurence A. officer: Chief Scientific Officer 22,312.0 M-Exempt D 7,438.0 0.00 0.00
2022-02-01 Turka Laurence A. officer: Chief Scientific Officer 4,921.0 S-Sale D 2,517.0 6.57 16,544.24
2022-02-01 Keson-Brookes Maiken officer: CLO & Corp. Secretary 34,500.0 A-Award D 34,500.0 0.00 0.00
2022-02-01 Keson-Brookes Maiken officer: CLO & Corp. Secretary 143,750.0 A-Award D 143,750.0 6.75 970,312.50
2022-02-01 Keson-Brookes Maiken officer: CLO & Corp. Secretary 24,225.0 M-Exempt D 8,075.0 0.00 0.00
2022-02-01 Keson-Brookes Maiken officer: CLO & Corp. Secretary 5,343.0 S-Sale D 2,732.0 6.57 17,957.44
2022-01-31 Appelhans Dannielle officer: Chief Operating Officer 30,000.0 A-Award A 30,000.0 0.00 0.00
2022-01-31 Appelhans Dannielle officer: Chief Operating Officer 125,000.0 A-Award A 125,000.0 6.75 843,750.00
2022-01-31 Carmona Jose officer: Chief Financial Officer 34,500.0 A-Award A 34,500.0 0.00 0.00
2022-01-31 Carmona Jose officer: Chief Financial Officer 143,750.0 A-Award A 143,750.0 6.75 970,312.50
2022-01-29 CAGNONI PABLO J director, officer: CEO and President 42,250.0 M-Exempt A 21,250.0 0.00 0.00
2022-01-29 Turka Laurence A. officer: Chief Scientific Officer 7,438.0 M-Exempt A 7,438.0 0.00 0.00
2022-01-29 Keson-Brookes Maiken officer: CLO & Corp. Secretary 8,075.0 M-Exempt A 8,075.0 0.00 0.00
2021-08-31 Appelhans Dannielle officer: Chief Operating Officer 50,000.0 A-Award A 50,000.0 0.00 0.00
2021-08-31 Appelhans Dannielle officer: Chief Operating Officer 150,000.0 A-Award A 150,000.0 21.72 3,258,000.00
2021-06-16 CAGNONI PABLO J director, officer: CEO and President 29,320.0 G-Gift D 2,200.0 0.00 0.00
2021-05-12 Epstein David R director 27,919.0 A-Award A 27,919.0 23.25 649,116.75
2021-05-12 Rosenblatt Michael director 25,000.0 A-Award A 25,000.0 23.25 581,250.00
2021-05-12 Sohn Catherine A. director 25,000.0 A-Award A 25,000.0 23.25 581,250.00
2021-05-12 AFEYAN NOUBAR director, 10 percent owner 25,000.0 A-Award A 25,000.0 23.25 581,250.00
2021-05-12 Symonds Jonathan director 25,000.0 A-Award A 25,000.0 23.25 581,250.00
2021-05-12 Prener Anne director 25,000.0 A-Award A 25,000.0 23.25 581,250.00
2021-05-12 Holles Natalie C. director 25,000.0 A-Award A 25,000.0 23.25 581,250.00
2021-05-12 Cuss Francis M director 25,000.0 A-Award A 25,000.0 23.25 581,250.00
2021-04-26 CAGNONI PABLO J director, officer: CEO and President 31,520.0 G-Gift D 4,000.0 0.00 0.00
2021-03-19 Flagship Ventures Fund IV General Partner LLC director, 10 percent owner 5,859,414.0 P-Purchase A 70,000.0 29.00 2,030,000.00
2021-03-19 Flagship Ventures Fund IV General Partner LLC director, 10 percent owner 2,633,703.0 P-Purchase A 70,000.0 29.00 2,030,000.00
2021-03-19 Flagship Ventures Fund IV General Partner LLC director, 10 percent owner 15,393,593 P-Purchase A 70,000.0 29.00 2,030,000.00
2021-03-15 Keson-Brookes Maiken officer: CLO & Corp. Secretary 225,000.0 M-Exempt D 25,000.0 7.70 192,500.00
2021-03-15 Keson-Brookes Maiken officer: CLO & Corp. Secretary 25,000.0 M-Exempt A 25,000.0 7.70 192,500.00
2021-03-15 Keson-Brookes Maiken officer: CLO & Corp. Secretary 0.0 S-Sale D 25,000.0 7.70 192,500.00
2021-02-11 Epstein David R director 4,690,012.0 S-Sale D 26,704.0 14.93 398,559.87
2021-02-10 Epstein David R director 4,716,716.0 S-Sale D 7,404.0 14.79 109,525.15
2021-02-09 Epstein David R director 4,724,120.0 S-Sale D 2,100.0 14.83 31,145.94
2021-02-08 Epstein David R director 4,726,220.0 S-Sale D 89,233.0 14.88 1,328,117.20
2021-01-29 CAGNONI PABLO J director, officer: CEO and President 375,000.0 A-Award A 375,000.0 11.97 4,488,750.00
2021-01-29 CAGNONI PABLO J director, officer: CEO and President 85,000.0 A-Award A 85,000.0 0.00 0.00
2021-01-29 Keson-Brookes Maiken officer: CLO & Corp. Secretary 142,500.0 A-Award A 142,500.0 11.97 1,705,725.00
2021-01-29 Coughlin Christina M. officer: Chief Medical Officer 142,500.0 A-Award A 142,500.0 11.97 1,705,725.00
2021-01-29 Coughlin Christina M. officer: Chief Medical Officer 32,300.0 A-Award A 32,300.0 0.00 0.00
2021-01-29 Turka Laurence A. officer: Chief Scientific Officer 131,250.0 A-Award A 131,250.0 11.97 1,571,062.50
2021-01-29 Turka Laurence A. officer: Chief Scientific Officer 29,750.0 A-Award A 29,750.0 0.00 0.00
2021-01-29 Keson-Brookes Maiken officer: CLO & Corp. Secretary 32,300.0 A-Award A 32,300.0 0.00 0.00
2020-11-30 Carmona Jose officer: Chief Financial Officer 400,000.0 A-Award A 400,000.0 6.27 2,508,000.00
2020-05-21 Holles Natalie C. director 25,000.0 A-Award A 25,000.0 6.22 155,500.00
2020-05-21 Sohn Catherine A. director 25,000.0 A-Award A 25,000.0 6.22 155,500.00
2020-05-21 AFEYAN NOUBAR director, 10 percent owner 25,000.0 A-Award A 25,000.0 6.22 155,500.00
2020-05-21 Symonds Jonathan director 25,000.0 A-Award A 25,000.0 6.22 155,500.00
2020-05-21 Epstein David R director 115,771.0 A-Award A 115,771.0 6.22 720,095.62
2020-05-21 Cuss Francis M director 25,000.0 A-Award A 25,000.0 6.22 155,500.00
2020-05-21 Rosenblatt Michael director 25,000.0 A-Award A 25,000.0 6.22 155,500.00
2020-05-15 OH ANDREW M. officer: Chief Financial Officer 5,000.0 M-Exempt A 5,000.0 4.74 23,700.00
2020-05-15 OH ANDREW M. officer: Chief Financial Officer 755,500.0 M-Exempt D 5,000.0 4.74 23,700.00
2020-04-22 Coughlin Christina M. officer: Chief Medical Officer 19,000.0 P-Purchase A 19,000.0 5.52 104,813.50
2020-04-14 CAGNONI PABLO J director, officer: CEO and President 21,000.0 P-Purchase A 21,000.0 4.70 98,693.70
2020-03-17 Epstein David R director 4,815,453.0 P-Purchase A 5,000.0 3.76 18,800.00
2020-03-13 Epstein David R director 4,805,453.0 P-Purchase A 5,000.0 4.00 20,000.00
2020-03-13 Epstein David R director 4,810,453.0 P-Purchase A 5,000.0 4.00 20,000.00
2020-01-31 Coughlin Christina M. officer: Chief Medical Officer 375,000.0 A-Award A 375,000.0 7.80 2,925,000.00
2020-01-31 Turka Laurence A. officer: Chief Scientific Officer 350,000.0 A-Award A 350,000.0 7.80 2,730,000.00
2020-01-31 OH ANDREW M. officer: Chief Financial Officer 165,000.0 A-Award A 165,000.0 7.80 1,287,000.00
2020-01-31 CAGNONI PABLO J director, officer: CEO and President 500,000.0 A-Award A 500,000.0 7.80 3,900,000.00
2019-12-31 Prener Anne director 50,000.0 A-Award A 50,000.0 9.50 475,000.00
2019-12-16 CARPENTER CHRISTOPHER L. officer: Chief Medical Officer 34,843.0 S-Sale D 48,000.0 2.87 137,760.00
2019-12-16 CARPENTER CHRISTOPHER L. officer: Chief Medical Officer 523,157.0 M-Exempt D 48,000.0 2.87 137,760.00
2019-12-16 CARPENTER CHRISTOPHER L. officer: Chief Medical Officer 82,843.0 M-Exempt A 48,000.0 2.87 137,760.00
2019-11-29 Keson-Brookes Maiken officer: CLO & Corp. Secretary 250,000.0 A-Award A 250,000.0 7.70 1,925,000.00
2019-10-14 LANGER ROBERT director 120,000.0 M-Exempt D 7,500.0 0.15 1,125.00
2019-10-14 LANGER ROBERT director 7,500.0 M-Exempt A 7,500.0 0.15 1,125.00
2019-10-14 LANGER ROBERT director 0.0 S-Sale D 7,500.0 0.15 1,125.00
2019-09-17 CARPENTER CHRISTOPHER L. officer: Chief Medical Officer 46,720.0 M-Exempt A 11,877.0 10.05 119,309.22
2019-09-17 CARPENTER CHRISTOPHER L. officer: Chief Medical Officer 34,843.0 S-Sale D 11,877.0 10.05 119,309.22
2019-09-17 CARPENTER CHRISTOPHER L. officer: Chief Medical Officer 571,157.0 M-Exempt D 11,877.0 10.05 119,309.22
2019-09-16 CARPENTER CHRISTOPHER L. officer: Chief Medical Officer 70,966.0 M-Exempt A 36,123.0 2.87 103,673.01
2019-09-16 CARPENTER CHRISTOPHER L. officer: Chief Medical Officer 34,843.0 S-Sale D 36,123.0 2.87 103,673.01
2019-09-16 CARPENTER CHRISTOPHER L. officer: Chief Medical Officer 583,034.0 M-Exempt D 36,123.0 2.87 103,673.01
2019-07-24 NISSEN TORBEN STRAIGHT officer: President 2,052,450.0 M-Exempt A 32,146.0 0.19 6,107.74
2019-07-24 NISSEN TORBEN STRAIGHT officer: President 2,020,304.0 M-Exempt A 175,000.0 0.18 31,500.00
2019-07-24 NISSEN TORBEN STRAIGHT officer: President 175,000.0 M-Exempt D 175,000.0 0.18 31,500.00
2019-07-24 NISSEN TORBEN STRAIGHT officer: President 82,854.0 M-Exempt D 32,146.0 0.19 6,107.74
2019-07-15 LANGER ROBERT director 127,500.0 M-Exempt D 7,500.0 0.15 1,125.00
2019-07-15 LANGER ROBERT director 7,500.0 M-Exempt A 7,500.0 0.15 1,125.00
2019-07-15 LANGER ROBERT director 0.0 S-Sale D 7,500.0 0.15 1,125.00
2019-06-20 CARPENTER CHRISTOPHER L. officer: Chief Medical Officer 35,086.0 M-Exempt A 243.0 2.87 697.41
2019-06-20 CARPENTER CHRISTOPHER L. officer: Chief Medical Officer 34,843.0 S-Sale D 243.0 2.87 697.41

Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Group doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Group or anyone involved with Discounting Cash Flows Group will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.